NIH-funded research R01 grant

Understanding how carfentanil causes breathing problems and death

Official title: Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death

Funded at Lovelace Biomedical Research Institute · NIH-11078227 · Data updated 2026-11-12

This study is looking into how carfentanil, a very strong opioid, can harm breathing and aims to find ways to help people who might be affected by it, especially during an overdose.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLovelace Biomedical Research Institute
NIH-funded
Lab location1 site (Albuquerque, United States)
Project startJune 1, 2023
Project endApril 30, 2026
Funding year2025
Award (this year)$651,000
NIH project number5R01DA059063-03
Project IDNIH-11078227 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced or are at risk of opioid overdose, particularly those exposed to carfentanil.

Less likely to help

Patients who are not affected by opioid use or who do not have respiratory disorders related to opioid exposure may not benefit from this research.

What this research studies

This research investigates the dangerous effects of carfentanil, a potent synthetic opioid, which can lead to severe respiratory disorders and death. The study aims to uncover the mechanisms by which carfentanil affects the body's ability to breathe, particularly focusing on how it interacts with specific receptors in the brain that control respiration. By examining these interactions, the researchers hope to identify effective countermeasures to prevent or treat carfentanil-induced respiratory failure. The approach includes both animal models and potential therapeutic interventions to improve outcomes for those affected by opioid overdoses.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively counteract the life-threatening respiratory effects of carfentanil and similar opioids.

How similar studies have gone: While there have been studies on opioid overdose treatments, the specific mechanisms and countermeasures for carfentanil-induced respiratory issues are still largely untested, making this research novel.

Where this research is happening

  • Lovelace Biomedical Research Institute
    Albuquerque, United States
    Active

Researchers

  • Principal investigator: Xu, Fadi — Lovelace Biomedical Research Institute
  • Study coordinator: Xu, Fadi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.